590th MEETING, SHEFFIELD 9 amino acids. In prolonged starvation it is known that ketonebody utilization by tissues such as brain increases whereas hepatic gluconeogenesis from amino acids is greatly suppressed. Palaiologis & Felig, 1976). Less work has been done on the converse situation: the effect of alanine or other amino acids on ketogenesis. Certain amino acids are ketogenic as such, and we have found marked rises in circulating ketone-body concentrations after leucine administration to insulin-deprived man. Alanine, however, has the opposite effect. Genuth & Castro (1974) and Sann et al. (1978) have shown that oral and intravenous alanine administration causes a fall in blood ketone-body concentration in man, and Ozand et al. (1977, 1978), in work with the rat, have attributed this to a direct hepatic effect.
al., 1975; Palaiologis & Felig, 1976) . Less work has been done on the converse situation: the effect of alanine or other amino acids on ketogenesis. Certain amino acids are ketogenic as such, and we have found marked rises in circulating ketone-body concentrations after leucine administration to insulin-deprived man. Alanine, however, has the opposite effect. Genuth & Castro (1974) and Sann et al. (1978) have shown that oral and intravenous alanine administration causes a fall in blood ketone-body concentration in man, and Ozand et al. (1977, 1978) , in work with the rat, have attributed this to a direct hepatic effect.
We have confirmed this latter finding, and have also shown an antiketogenic effect of aspartate (Nosadini et al., 1980) . The results suggest that both alanine and aspartate are antiketogenic through increasing oxaloacetate availability and diverting acetyl-CoA from ketogenesis to citrate formation, although other mechanisms may also be involved. The reported studies in man are complicated by the stimulatory effects of alanine on both insulin and glucagon secretion. We have, however, now shown a clear antiketogenic effect of alanine in man when insulin and glucagon secretion are simultaneously suppressed with somatostatin. This inverse negative relationship between alanine and ketone-body metabolism could have an important regulatory role, particularly in stress states, where marked deviations are found for the normal physiological relationships of protein and fat metabolism.
In conclusion, ketogenesis is influenced by many factors in uiuo, working both extrahepatically and in the liver. Many hormones are involved in these processes, but in addition subtle interactions with other metabolic pathways are also important. Acetyl-coenzyme A carboxylase I acetyl-CoA-CO, ligase (ADP-forming), EC 6.4.1.21 mediates the initial step in the biosynthetic sequence leading specifically to long-chain fatty acids and plays a critical role in the control of this synthetic process (Numa el al., 1970) . The regulation of acetyl-CoA carboxylase is effected by changes both in the cellular content and in the catalytic efficiency of the enzyme. The cellular content of acetyl-CoA carboxylase varies under different metabolic conditions, including nutritional alteration, diabetes, obesity and development, which are associated with changes in the rate of fatty-acid synthesis (Numa & Yamashita, 1974) . It is well established that the variations in the enzyme content are due principally to corresponding changes in the rate of synthesis of the enzyme, whereas the degradation of the enzyme plays no significant role except in a non-steady state like starvation (Numa & Yamashita, 1974) . Our studies along this line have therefore been focused on the molecular mechanism underlying the regulation of synthesis of acetyl-CoA carboxylase, specifically on two questions, i.e. at which step of protein synthesis the rate of synthesis of the enzyme is regulated and which metabolite is responsible for its control? Variations in the cellular content of acetyl-CoA carboxylase are involved in the long-term regulation of fatty-acid synthesis, whereas the allosteric modulation of the catalytic efficiency of the enzyme is important for its short-term regulation (Numa & Yamashita, 1974) . Concerning the latter aspect, our recent studies have been directed to the mechanism and specificity of inhibition of acetyl-CoA carboxylase. Evidence is presented in this paper to indicate that long-chain acyl-CoA plays an essential role in the regulation of acetyl-CoA carboxylase in both ways.
Regulation of acetyl-CoA carboxylase mRNA
Our previous studies have demonstrated that the synthesis and therefore the content) of acetyl-CoA carboxylase in cultured hepatocytes as well as in yeast is diminished when fatty acid is added to culture medium (Kitajima et al., 1975;  Kamiryo & Numa, 1973; Mishina et al., 1976) . For studying the mechanism responsible for the repression of acetyl-CoA carboxylase, the hydrocarbon-utilizing yeast Candida lipolytica represents a useful eukaryotic system because this yeast is capable of utilizing fatty acid (or n-alkane) as well as glucose as a sole carbon source and thus exhibits large variations in the rate of synthesis of the enzyme. We have recently been able to synthesize complete acetyl-CoA carboxylase ( M , 230000), using mRNA from C. lipolytica and a reticulocyte lysate cell-free translation system (Horikawa et al., 1980) . This assay system has enabled us to demonstrate that the level of acetyl-CoA carboxylase mRNA in C. Iipolytica cells decreases with increasing concentrations of fatty acid in culture medium in parallel with the cellular level of the enzyme, as shown in Fig. 1 . It is therefore concluded that the repression of acetyl-CoA carboxylase is effected at the pretranslational level. In accord with this conclusion is our previous finding, based on '2JI-labelled antibody binding and polyribosome 'run-off' experiments, that the hepatic content of acetyl-CoA carboxylase-synthesizing polyribosomes reflects the rate of synthesis of the enzyme in animals subjected to different dietary, hormonal or genetic conditions (Nakanishi et 
Two functionally distinct long-chain acyl-CoA synthetases
Our efforts have next been directed to the question, which metabolite is responsible for the repression of acetyl-CoA carboxylase? In an attempt to determine whether the repressive effect is mediated by fatty acid itself or a metabolite derived from it, we isolated mutant strains of C. lipolytica that exhibited apparently no activity of long-chain acyl-CoA synthetase [acid-CoA ligase (AMP-forming), EC 6.2.1.31 . The mutants were selected by their inability to grow in the presence of exogenous fatty acid under conditions where the cellular synthesis de nouo of fatty acids was blocked by cerulenin. Because the activation of exogenous fatty acid is an obligatory step for its further metabolism, it was unexpected that these mutants were capable of growing on fatty acid (or n-alkane) as a sole carbon source. This phenotype has been understood, however, by the finding that the mutant strains, unlike the wild-type strain, cannot incorporate exogenous fatty acid as a whole into cellular lipids, but are able to degrade it to yield acetyl-CoA, from which cellular fatty acids are synthesized de novo (Kamiryo et al., 1977) . Moreover, this finding has led to the discovery of a second long-chain acylCoA synthetase, which occurs in the mutant strains as well as in the wild-type strain (Mishina el al., 19780) . This enzyme, designated as acyl-CoA synthetase 11, requires phosphatidylcholine for its activity and can be separated from phosphatidylcholine-independent acyl-CoA synthetase I, which is missing in the mutant strains. Acyl-CoA synthetase I has been purified to homogeneity, and the two acyl-CoA synthetases are immunochemically distinguishable from each other (Hosaka et al., 1979). Thus, it has been concluded that acyl-CoA synthetase I is responsible for the production of long-chain acylCoA to be utilized for the synthesis of cellular lipids, whereas acyl-CoA synthetase I1 provides long-chain acyl-CoA that is exclusively degraded via /3-oxidation. Consistent with this conclusion is the fact that acyl-CoA synthetase 11, in contrast with acyl-CoA synthetase I, is induced by fatty acid and exhibits a broad substrate specificity with respect to fatty acid (Mishina et al., 1978a) . In further support of the different physiological roles of the two long-chain acyl-CoA synthetases, their subcellular localizations are different (Mishina et al., 19786) . Acyl-CoA synthetase I is distributed among various subcellular fractions, including microsomes and mitochondria where glycerol phosphate acyltransferase is located, whereas acyl-CoA synthetase I1 is localized in microbodies where the acyl-CoA-oxidizing system is located. From the findings described above, it may be inferred that the cell of C . lipolytica has two independent long-chain acylCoA pools, one destined for lipid synthesis and the other for 8-oxidation. To prove this hypothesis, we isolated additional mutant strains of C. lipo&ica that were defective in acyl-CoA synthetase I1 and that completely failed to grow on fatty acid as a sole carbon source (Kamiryo et al., 1979) . This phenotype, in conjunction with that of the acyl-CoA synthetase I mutants mentioned above, indicates clearly that the long-chain acylCoA produced by acyl-CoA synthetase I is utilized solely for lipid synthesis, whereas that produced by acyl-CoA synthetase I1 is destined exclusively for /3-oxidation (see Fig. 3) .
Involvement of the long-chain acyl-CoA for lipid synthesis in repression of acetyl-CoA carboxylase
As described above, the wild-type strain of C . lipolytica exhibits a repression of acetyl-CoA carboxylase when it is grown in the presence of fatty acid. In contrast, the acetyl-CoA carboxylase level in the mutants defective in acyl-CoA synthetase I is hardly decreased by exogenous fatty acid (Kamiryo et al., 1979) . The mutants defective in acyl-CoA synthetase I1 as well as the revertants derived from an acyl-CoA synthetase I mutant response normally to exogenous fatty acid. Thus, it is evident that the activity of acyl-CoA synthetase I, but not that of acyl-CoA synthetase 11, is required for the repression of acetyl-CoA carboxylase.
In the 'experiment represented in Fig. 2 , we attempted to measure separately the two independent long-chain acyl-CoA pools provided by acyl-CoA synthetase 1 and acyl-CoA i - Fig. 3 . Functions of the two long-chain acyl-CoP synthetases and the mechanism of repression of acetyl-CoA carboxylase synthetase 11, using appropriate mutant strains. When fatty acid is added to culture medium at increasing concentrations, the mutant defective in acyl-CoA synthetase I1 (Fig. 24) should accumulate the long-chain acyl-CoA to be utilized for lipid synthesis, whereas the mutant lacking acyl-CoA synthetase I (and also the acyl-CoA-oxidizing system) (Fig. 2c) should accumulate the long-chain acyl-CoA destined for 8-oxidation. On the other hand, the mutant defective in both acyl-CoA synthetases (Fig. 2b) should produce no long-chain acyl-CoA from exogenous fatty acid. The repression of acetyl-CoA carboxylase is observed in the mutant defective in acyl-CoA synthetase 11, but not in the other two mutants. These results clearly indicate that the long-chain acyl-CoA to be utilized for lipid. synthesis is causally related to the repression of acetyl CoA carboxylase, whereas the long-chain acyl-CoA to be degraded via 8-oxidation is not involved in this repression. This regulatory mechanism is obviously of teleological significance in view of the homoeostasis of lipid synthesis, as schematically shown in Fig. 3 . The long-chain acyl-CoA VOl. 9 destined for lipid synthesis is supplied both by fatty-acid synthesis de nouo, the rate of which is regulated by acetyl-CoA carboxylase, and by the activation of exogenous fatty acid catalysed by acyl-CoA synthetase I. It seems probable that the long-chain acyl-CoA to be utilized for lipid synthesis, or a compound metabolically related to it, acts as a co-repressor or its eukaryotic equivalent to suppress the expression of the acetyl-CoA carboxylase gene.
Fatty acid

Regulation of the catalytic eficiency of acetyl-CoA carboxylase
It is well known that acetyl-CoA carboxylase is inhibited by long-chain acyl-CoA thioesters (Bortz 8c Lynen, 1963; Numa et al., 1965) . The mechanism and specificity of this inhibition have been extensively studied with pure rat liver acetyl-CoA carboxylase by means of the kinetics of tightbinding inhibitors and [ ''Clpalmitoyl-CoA binding experiments (Ogiwara et al., 1978) . One mol of palmitoyl-CoA completely inhibits 1 mol of acetyl-CoA carboxylase, the inhibition constant (K,) being as low as 6 n~; this value is about three orders of magnitude smaller than the critical micellar concentration of palmitoyl-CoA. The enzyme, when preincubated with palmitoyl-CoA in low molar ratios (inhibitor/enzyme 5 S), is associated with an equimolar amount of the inhibitor, assuming the 'small', inactive molecular form. The activator citrate, which competes kinetically with palmitoyl-CoA (Numa et al., 1965) , not only prevents this equimolar association, but also dissociates the equimolar enzyme-inhibitor complex. The enzyme thus freed from the inhibitor assumes the 'large', active molecular form and regains its full activity. In contrast, the enzyme, when preincubated with palmitoyl-CoA in high molar ratios (inhibitor/enzyme 2 20), binds a large molar excess of the inhibitor and is further dissociated into the monomeric subunit as is the enzyme treated with sodium dodecyl sulphate. In this case, the enzyme cannot be reactivated by citrate. Thus, it is concluded that palmitoyl-CoA binds tightly and reversibly to the enzyme in an equimolar ratio to inhibit it. Comparison of the K, values for various structural analogues of palmitoyl-CoA indicates that the 3'-phosphate of the CoA moiety and the long-chain acyl residue are essen-tial for the inhibition of the enzyme (Nikawa et al., 1979) . The reversible formation of the equimolar enzyme-inhibitor complex, together with the rather strict structural requirement for the inhibitor, strongly supports the concept that longchain acyl-CoA is a physiological regulator of acetyl-CoA carboxylase.
Conclusion
Long-chain acyl-CoA plays dual roles in the regulation of acetyl-CoA carboxylase, the rate-limiting enzyme for the control of fatty-acid biosynthesis. The long-chain acyl-CoA to be utilized for lipid synthesis, but not that to be degraded via poxidation, is involved in the repression of the enzyme, which results from a decreased level of the mRNA coding for the enzyme. On the other hand, the enzyme is specifically inhibited by long-chain acyl-CoA, which binds tightly
